Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+7.30%)
As of: Oct 23, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Amortization of Deferred Charges (2013 - 2026)

Updated

Analysis

Citius Pharmaceuticals (CTXR) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.47 Mn -23.10 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 179,492.00
Dec 31, 2021 42,879.00
Sep 30, 2021 42,037.00
Jun 30, 2021 41,227.00
Mar 31, 2021 40,441.00
Dec 31, 2020 39,671.00
Sep 30, 2020 38,915.00
Jun 30, 2020 30,758.00
Mar 31, 2020 47,278.00
Dec 31, 2019 34,569.00
Jun 30, 2014 3,500.00
Mar 31, 2014 10,500.00
Dec 31, 2013 10,500.00
API Access

Citius Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CTXR&period=max&api_key=YOUR_API_KEY